Social implications of a change in the legal classification of COVID-19: The need for pandemic prevention, preparedness, and healthcare system strengthening

In Japan, there has been a discussion of the potential reclassification of the novel coronavirus infectious disease 2019 (COVID-19) as an infectious disease under the Act on the Prevention of Infectious Diseases and Medical Care for Patients with Infectious Diseases (the Infectious Diseases Control...

Full description

Saved in:
Bibliographic Details
Published inGlobal Health & Medicine Vol. 5; no. 2; pp. 75 - 77
Main Author Ohmagari, Norio
Format Journal Article
LanguageEnglish
Published Japan National Center for Global Health and Medicine 30.04.2023
Subjects
Policy Forum
public health
the Infectious Diseases Control Law
transmissibility of infection
the Infectious Diseases Control Law
public health
transmissibility of infection
Online AccessGet full text

Cover

Abstract In Japan, there has been a discussion of the potential reclassification of the novel coronavirus infectious disease 2019 (COVID-19) as an infectious disease under the Act on the Prevention of Infectious Diseases and Medical Care for Patients with Infectious Diseases (the Infectious Diseases Control Law), beginning in late 2022. To make an informed decision, the societal impact of COVID-19 needs to be carefully considered to ensure that any reclassification does not negatively impact healthcare or society as a whole. The disease burden of COVID-19 remains considerable and is likely to persist for an extended period of time. Consequently, numerous special measures have been taken in the healthcare system to cope with COVID-19. Several of these measures must be implemented. Thus, the healthcare system needs to be strengthened in the future. This will result in adequate prevention, preparation, and a response to future pandemics.
AbstractList In Japan, there has been a discussion of the potential reclassification of the novel coronavirus infectious disease 2019 (COVID-19) as an infectious disease under the Act on the Prevention of Infectious Diseases and Medical Care for Patients with Infectious Diseases (the Infectious Diseases Control Law), beginning in late 2022. To make an informed decision, the societal impact of COVID-19 needs to be carefully considered to ensure that any reclassification does not negatively impact healthcare or society as a whole. The disease burden of COVID-19 remains considerable and is likely to persist for an extended period of time. Consequently, numerous special measures have been taken in the healthcare system to cope with COVID-19. Several of these measures must be implemented. Thus, the healthcare system needs to be strengthened in the future. This will result in adequate prevention, preparation, and a response to future pandemics.In Japan, there has been a discussion of the potential reclassification of the novel coronavirus infectious disease 2019 (COVID-19) as an infectious disease under the Act on the Prevention of Infectious Diseases and Medical Care for Patients with Infectious Diseases (the Infectious Diseases Control Law), beginning in late 2022. To make an informed decision, the societal impact of COVID-19 needs to be carefully considered to ensure that any reclassification does not negatively impact healthcare or society as a whole. The disease burden of COVID-19 remains considerable and is likely to persist for an extended period of time. Consequently, numerous special measures have been taken in the healthcare system to cope with COVID-19. Several of these measures must be implemented. Thus, the healthcare system needs to be strengthened in the future. This will result in adequate prevention, preparation, and a response to future pandemics.
In Japan, there has been a discussion of the potential reclassification of the novel coronavirus infectious disease 2019 (COVID-19) as an infectious disease under the Act on the Prevention of Infectious Diseases and Medical Care for Patients with Infectious Diseases (the Infectious Diseases Control Law), beginning in late 2022. To make an informed decision, the societal impact of COVID-19 needs to be carefully considered to ensure that any reclassification does not negatively impact healthcare or society as a whole. The disease burden of COVID-19 remains considerable and is likely to persist for an extended period of time. Consequently, numerous special measures have been taken in the healthcare system to cope with COVID-19. Several of these measures must be implemented. Thus, the healthcare system needs to be strengthened in the future. This will result in adequate prevention, preparation, and a response to future pandemics.
ArticleNumber 2023.01018
Author Ohmagari, Norio
Author_xml – sequence: 1
  fullname: Ohmagari, Norio
  organization: National Center for Global Health and Medicine, Tokyo, Japan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37128230$$D View this record in MEDLINE/PubMed
BookMark eNp1kstu1DAYhSNUREvpmh3ykkUz9SWe2GwQDLdKlbqgsLUc53di5DjBzlTqu_CwODPTESCxsGzZ3znH8vHz4iSMAYriJcErxuuaXnX9sKKYshUmmIgnxRmtWFVKIquT41qsT4uLlFyDK1oRJgV-VpyymlBBGT4rfn0djdMeuWHyzujZjSGh0SKNTK9DB8gFNPeAPHSZMl5nK3sAF25z-_36Q0nkG3SXqQDQIjtGNOnQwuAMmiLcQ1joy2U96QhtgJQuUSZQD9rPvcmbKD2kGQaU5gihy4nBhe5F8dRqn-DiMJ8X3z59vNt8KW9uP19v3t2Uhtd0Lqm1Tc0pIWvCK8nr1tYAvG4ssZLRRsuKtIxwDkJKuia2xUxyKbQUtSENFuy8eLv3nbbNAK3JF47aqym6QccHNWqn_j4JrlfdeK_yszPMq3V2eH1wiOPPLaRZDS4Z8F4HGLdJUYEFF3WFeUZf_Rl2THnsJAN8D5g4phTBKuPm3YPnbOdzqNrVr3L9aqlf7erPuqt_dI_W_1e83yt-pFl3cOR1nJ3xsMO5oss4io6H-X9EBYH9BoMfy3Q
CitedBy_id crossref_primary_10_24171_j_phrp_2023_0372
Cites_doi 10.1136/heartjnl-2022-321492
10.1016/j.ijid.2022.05.031
10.1038/s41579-022-00846-2
ContentType Journal Article
Copyright 2023 National Center for Global Health and Medicine
2023, National Center for Global Health and Medicine.
2023, National Center for Global Health and Medicine 2023
Copyright_xml – notice: 2023 National Center for Global Health and Medicine
– notice: 2023, National Center for Global Health and Medicine.
– notice: 2023, National Center for Global Health and Medicine 2023
DBID AAYXX
CITATION
NPM
7X8
5PM
DOI 10.35772/ghm.2023.01018
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
EISSN 2434-9194
EndPage 77
ExternalDocumentID PMC10130546
37128230
10_35772_ghm_2023_01018
article_ghm_5_2_5_2023_01018_article_char_en
Genre Journal Article
Review
GroupedDBID ALMA_UNASSIGNED_HOLDINGS
JSF
JSH
RJT
RPM
RZJ
AAYXX
CITATION
NPM
7X8
5PM
ID FETCH-LOGICAL-c572t-2ffb752116154957df7ee57bf1f932ba941d3155e899261fd039598a987c1b083
ISSN 2434-9186
2434-9194
IngestDate Thu Aug 21 18:37:51 EDT 2025
Thu Jul 10 19:11:18 EDT 2025
Thu Jan 02 22:52:33 EST 2025
Thu Apr 24 23:14:50 EDT 2025
Tue Jul 01 03:36:53 EDT 2025
Sun Jul 28 05:37:20 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords the Infectious Diseases Control Law
public health
transmissibility of infection
Language English
License 2023, National Center for Global Health and Medicine.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c572t-2ffb752116154957df7ee57bf1f932ba941d3155e899261fd039598a987c1b083
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
OpenAccessLink https://www.jstage.jst.go.jp/article/ghm/5/2/5_2023.01018/_article/-char/en
PMID 37128230
PQID 2808587405
PQPubID 23479
PageCount 3
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_10130546
proquest_miscellaneous_2808587405
pubmed_primary_37128230
crossref_citationtrail_10_35772_ghm_2023_01018
crossref_primary_10_35772_ghm_2023_01018
jstage_primary_article_ghm_5_2_5_2023_01018_article_char_en
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20230430
PublicationDateYYYYMMDD 2023-04-30
PublicationDate_xml – month: 4
  year: 2023
  text: 20230430
  day: 30
PublicationDecade 2020
PublicationPlace Japan
PublicationPlace_xml – name: Japan
PublicationTitle Global Health & Medicine
PublicationTitleAlternate GHM
PublicationYear 2023
Publisher National Center for Global Health and Medicine
Publisher_xml – name: National Center for Global Health and Medicine
References 1. Ministry of Health, Labour and Welfare. Severity and mortality of cases of COVID-19 2022. https://www.mhlw.go.jp/content/10900000/001027743.pdf (accessed March 8, 2023). (in Japanese)
3. Xue L, Jing S, Zhang K, Milne R, Wang H. Infectivity versus fatality of SARS-CoV-2 mutations and influenza. Int J Infect Dis. 2022; 121:195-202.
2. Raisi-Estabragh Z, Cooper J, Salih A, Raman B, Lee AM, Neubauer S, Harvey NC, Petersen SE. Cardiovascular disease and mortality sequelae of COVID-19 in the UK Biobank. Heart. 2022; 109:119-126.
4. Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023; 21:133-146.
1
2
3
4
References_xml – reference: 1. Ministry of Health, Labour and Welfare. Severity and mortality of cases of COVID-19 2022. https://www.mhlw.go.jp/content/10900000/001027743.pdf (accessed March 8, 2023). (in Japanese)
– reference: 4. Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023; 21:133-146.
– reference: 2. Raisi-Estabragh Z, Cooper J, Salih A, Raman B, Lee AM, Neubauer S, Harvey NC, Petersen SE. Cardiovascular disease and mortality sequelae of COVID-19 in the UK Biobank. Heart. 2022; 109:119-126.
– reference: 3. Xue L, Jing S, Zhang K, Milne R, Wang H. Infectivity versus fatality of SARS-CoV-2 mutations and influenza. Int J Infect Dis. 2022; 121:195-202.
– ident: 2
  doi: 10.1136/heartjnl-2022-321492
– ident: 3
  doi: 10.1016/j.ijid.2022.05.031
– ident: 1
– ident: 4
  doi: 10.1038/s41579-022-00846-2
SSID ssib042413980
ssj0002512030
ssib044737821
Score 2.2260938
SecondaryResourceType review_article
Snippet In Japan, there has been a discussion of the potential reclassification of the novel coronavirus infectious disease 2019 (COVID-19) as an infectious disease...
SourceID pubmedcentral
proquest
pubmed
crossref
jstage
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 75
SubjectTerms Policy Forum
public health
the Infectious Diseases Control Law
transmissibility of infection
Title Social implications of a change in the legal classification of COVID-19: The need for pandemic prevention, preparedness, and healthcare system strengthening
URI https://www.jstage.jst.go.jp/article/ghm/5/2/5_2023.01018/_article/-char/en
https://www.ncbi.nlm.nih.gov/pubmed/37128230
https://www.proquest.com/docview/2808587405
https://pubmed.ncbi.nlm.nih.gov/PMC10130546
Volume 5
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Global Health & Medicine, 2023/04/30, Vol.5(2), pp.75-77
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagINQLAvFoeGmQOHBolsR5OIETKqCCRHtpUW9RnDjZrdrsqmwv_S39sczYceKsWgk4bLSbTOxVvi_jGXtmzNi7jNIO0lr5tchSP06Dxi9F3viC102VNo3Ma8pG_nmQ7h_HP06SkzHcVmeXrOWsuroxr-R_UMVziCtlyf4DskOjeAK_I754RITx-FcY97m1Czcq3OQ76pwBG8N4plqqAkJ2MgUGDUbi3uGv71_8MLeRFx2OZDrscEUzyxQ0v-oLPJmlefyl49VJO9qoz_kYP2aKQuvsk66logp2VDx1txfo79CU21zYP5yfl21pct8PlhcmRMzOSfDIWV5RWnfxOIpRj5r9i62iTRw-cUdpmq1TNnV5lKDhjwi0cyoYwKMZVcPLXEl8OqtzDW0kcJjl9h9MymfbS3fZPY4NcmdChwZrMu9Qz5miT7rLD9MOt9kD28TEdLl_itZ7q25yTDbjax2D5egRe9h7GvDZ0OYxu6O6J-zaUAZcysCygRIMZWDRAUIHmjIwpQzJWcp8BCQMEGEACQOWMDASZhdcuuwCSsBIFjBkgQlZnrLjb1-P9vb9foMOv0oEX_sc32WB9h95Dehoi7oRSiVCNmGDboEs8zisIzRYFTr16Kk3dRDlSZ6VeSaqUKLx_4xtdctO7TAIlIzqNBayQtKgiS0DKcs0lSHa52Ggco_N7LMvqr56PW2iclagF6txKxC3gnArNG4eez_csDKFW24X_WTAHAT7N1rLJQWnzyA9XKS0SNRCHntrGVCgaqb1trJTy8vfBc_Qn6EtLxOPPTeMGHqwnPJYNuHKIEBl36dXusVcl38PKdggidMXtzb6km2Pb-UrtrW-uFSv0XZeyzea_X8AVYrIAw
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Social+implications+of+a+change+in+the+legal+classification+of+COVID-19%3A+The+need+for+pandemic+prevention%2C+preparedness%2C+and+healthcare+system+strengthening&rft.jtitle=Global+health+%26+medicine&rft.au=Ohmagari%2C+Norio&rft.date=2023-04-30&rft.eissn=2434-9194&rft.volume=5&rft.issue=2&rft.spage=75&rft_id=info:doi/10.35772%2Fghm.2023.01018&rft_id=info%3Apmid%2F37128230&rft.externalDocID=37128230
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2434-9186&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2434-9186&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2434-9186&client=summon